Research programme: Baculovirus gene delivery systems - Trizell
Alternative Names: BacVLatest Information Update: 16 Sep 2010
At a glance
- Originator Ark Therapeutics
- Class Gene therapies
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Unspecified
Most Recent Events
- 09 Sep 2010 Discontinued - Preclinical for Undefined indication in Finland (unspecified route)
- 17 May 2010 Preclinical development is ongoing in Finland
- 05 Feb 2007 Preclinical trials in Age-related macular degeneration in Finland (unspecified route)